Literature DB >> 22401504

Ongoing epidemic of Mycoplasma pneumoniae infection in Jerusalem, Israel, 2010 to 2012.

R Nir-Paz1, A Abutbul, A E Moses, C Block, C Hidalgo-Grass.   

Abstract

A substantial epidemic of Mycoplasma pneumonia infection was reported in late 2011 in some European countries. We report here an epidemic of M. pneumonia infection that began in Jerusalem during 2010 and is still ongoing. This report complements current information on what might be a worldwide epidemic of M. pneumoniae infection that might require substantial coordinated international public health intervention.

Entities:  

Mesh:

Year:  2012        PMID: 22401504

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  23 in total

Review 1.  Mycoplasma pneumoniae from the Respiratory Tract and Beyond.

Authors:  Ken B Waites; Li Xiao; Yang Liu; Mitchell F Balish; T Prescott Atkinson
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

2.  Genetic diversity and macrolide resistance of Mycoplasma pneumoniae isolates from two consecutive epidemics in Slovenia.

Authors:  R Kogoj; M Praprotnik; T Mrvič; M Korva; D Keše
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-09-26       Impact factor: 3.267

3.  Molecular Epidemiology of Mycoplasma pneumoniae: Genotyping Using Single Nucleotide Polymorphisms and SNaPshot Technology.

Authors:  A Touati; Y Blouin; P Sirand-Pugnet; H Renaudin; T Oishi; G Vergnaud; C Bébéar; S Pereyre
Journal:  J Clin Microbiol       Date:  2015-07-22       Impact factor: 5.948

4.  Epidemiology and associations with climatic conditions of Mycoplasma pneumoniae and Chlamydophila pneumoniae infections among Chinese children hospitalized with acute respiratory infections.

Authors:  Zhengrong Chen; Wei Ji; Yuqing Wang; Yongdong Yan; Hong Zhu; Xuejun Shao; Jun Xu
Journal:  Ital J Pediatr       Date:  2013-05-25       Impact factor: 2.638

5.  The spread of Mycoplasma pneumoniae is polyclonal in both an endemic setting in France and in an epidemic setting in Israel.

Authors:  Sabine Pereyre; Alain Charron; Carlos Hidalgo-Grass; Arabella Touati; Allon E Moses; Ran Nir-Paz; Cécile Bébéar
Journal:  PLoS One       Date:  2012-06-06       Impact factor: 3.240

6.  Prevalence and correlation of infectious agents in hospitalized children with acute respiratory tract infections in Central China.

Authors:  Jia Liu; Hongwu Ai; Ying Xiong; Fu Li; Zhou Wen; Weiyong Liu; Tongya Li; Kai Qin; Jianguo Wu; Yingle Liu
Journal:  PLoS One       Date:  2015-03-09       Impact factor: 3.240

7.  Mycoplasma pneumoniae and Chlamydia spp. infection in community-acquired pneumonia, Germany, 2011-2012.

Authors:  Roger Dumke; Christiane Schnee; Mathias W Pletz; Jan Rupp; Enno Jacobs; Konrad Sachse; Gernot Rohde
Journal:  Emerg Infect Dis       Date:  2015-03       Impact factor: 6.883

8.  Multiple-locus variable-number tandem-repeat analysis of mycoplasma pneumoniae clinical specimens and proposal for amendment of MLVA nomenclature.

Authors:  Hongmei Sun; Guanhua Xue; Chao Yan; Shaoli Li; Ling Cao; Yi Yuan; Hanqing Zhao; Yanling Feng; Liqiong Wang; Zhaoyang Fan
Journal:  PLoS One       Date:  2013-05-30       Impact factor: 3.240

9.  Comparative "-omics" in Mycoplasma pneumoniae Clinical Isolates Reveals Key Virulence Factors.

Authors:  Maria Lluch-Senar; Luca Cozzuto; Jaime Cano; Javier Delgado; Verónica Llórens-Rico; Sabine Pereyre; Cécile Bebear; Luis Serrano
Journal:  PLoS One       Date:  2015-09-03       Impact factor: 3.240

10.  Mycoplasma pneumoniae infection in children is a risk factor for developing allergic diseases.

Authors:  Qing Ye; Xiao-Jun Xu; Wen-Xia Shao; Yan-Xiang Pan; Xue-Jun Chen
Journal:  ScientificWorldJournal       Date:  2014-04-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.